FACT /
29/09/2025
by TLJ
Johnson & Johnson Q1 2025 Earnings Report
N ews (0)
N ews (0)
Johnson & Johnson reported Q1 2025 sales of $21.9 billion, a 2.4% increase year-over-year. Adjusted EPS rose 2.2% to $2.77. The pharmaceutical segment led growth with a 4.2% operational increase, while medical devices and consumer health segments also saw positive results. The company is on track to achieve net cost savings of approximately $4.5 billion by the end of 2025
Must Read
Enry’s Island SpA Consolida la Leadership nel Venture Capital con Crescita Esplosiva e Ridisegna il Futuro del VC Attraverso il Gaming
BULLISH NEWS (4)
BEARISH NEWS (3)
Amazon’s Strong Q3 2023 Growth
BULLISH NEWS (3)
BEARISH NEWS (3)
Quarterly - Apple
BULLISH NEWS (3)
BEARISH NEWS (3)
Microsoft Corporation Q1 2025 highlights
BULLISH NEWS (1)
BEARISH NEWS (1)
Latest facts in Public Companies
Enry’s Island SpA Consolida la Leadership nel Venture Capital con Crescita Esplosiva e Ridisegna il Futuro del VC Attraverso il Gaming
by TLJ
12/02/2026
- Bullish News (4)
- Bearish News (3)
https://vimeo.com/1196233023?fl=ip&fe=ec
- Bullish News (3)
- Bearish News (3)
In the third quarter of 2023, Amazon.com, Inc. reported revenue of $143.1 billion, a 13% year-over-year increase, driven by strength in e-commerce, Read More....
- Bullish News (3)
- Bearish News (3)
Apple reported moderate revenue growth this quarter, with an improving business mix driven by high-margin services. Core hardware, particularly Read More....
- Bullish News (1)
- Bearish News (1)
Microsoft reported a 16% year-over-year revenue increase in Q1 2025, reaching $9.1 billion in additional revenue. The Intelligent Cloud segment saw a Read More....
